nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—RRM2—Hydroxyurea—psoriasis	0.63	1	CbGbCtD
Gallium nitrate—IL1B—synovial fluid—psoriasis	0.0201	0.156	CbGeAlD
Gallium nitrate—BGLAP—skeletal joint—psoriasis	0.0152	0.118	CbGeAlD
Gallium nitrate—IL1B—dermis—psoriasis	0.0151	0.117	CbGeAlD
Gallium nitrate—IL1B—skeletal joint—psoriasis	0.013	0.101	CbGeAlD
Gallium nitrate—BGLAP—vertebral column—psoriasis	0.0121	0.0938	CbGeAlD
Gallium nitrate—IL1B—vertebral column—psoriasis	0.0103	0.0802	CbGeAlD
Gallium nitrate—IL1B—synovial membrane of synovial joint—psoriasis	0.00989	0.0767	CbGeAlD
Gallium nitrate—TF—vertebral column—psoriasis	0.00923	0.0715	CbGeAlD
Gallium nitrate—IL1B—skin epidermis—psoriasis	0.00635	0.0492	CbGeAlD
Gallium nitrate—IL1B—endothelium—psoriasis	0.0046	0.0357	CbGeAlD
Gallium nitrate—ATP6V1B2—skin of body—psoriasis	0.00269	0.0208	CbGeAlD
Gallium nitrate—ATP6V1B2—tendon—psoriasis	0.00205	0.0159	CbGeAlD
Gallium nitrate—IL1B—skin of body—psoriasis	0.00197	0.0152	CbGeAlD
Gallium nitrate—TF—skin of body—psoriasis	0.00175	0.0136	CbGeAlD
Gallium nitrate—RRM2—skin of body—psoriasis	0.00173	0.0134	CbGeAlD
Gallium nitrate—IL1B—tendon—psoriasis	0.0015	0.0116	CbGeAlD
Gallium nitrate—RRM2—tendon—psoriasis	0.00132	0.0102	CbGeAlD
Gallium nitrate—Encephalopathy—Cyclosporine—psoriasis	0.000941	0.0101	CcSEcCtD
Gallium nitrate—Encephalopathy—Mycophenolate mofetil—psoriasis	0.000918	0.00982	CcSEcCtD
Gallium nitrate—Blindness—Triamcinolone—psoriasis	0.000913	0.00977	CcSEcCtD
Gallium nitrate—Optic neuritis—Prednisolone—psoriasis	0.000893	0.00956	CcSEcCtD
Gallium nitrate—Erythema—Clobetasol propionate—psoriasis	0.000879	0.00941	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Mycophenolic acid—psoriasis	0.000874	0.00936	CcSEcCtD
Gallium nitrate—Optic neuritis—Hydrocortisone—psoriasis	0.000872	0.00934	CcSEcCtD
Gallium nitrate—Hypersensitivity—Calcipotriol—psoriasis	0.000846	0.00905	CcSEcCtD
Gallium nitrate—Blindness—Dexamethasone—psoriasis	0.000828	0.00887	CcSEcCtD
Gallium nitrate—Blindness—Betamethasone—psoriasis	0.000828	0.00887	CcSEcCtD
Gallium nitrate—Optic neuritis—Triamcinolone—psoriasis	0.000821	0.00879	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Mycophenolic acid—psoriasis	0.000815	0.00873	CcSEcCtD
Gallium nitrate—Rales—Methotrexate—psoriasis	0.000813	0.00871	CcSEcCtD
Gallium nitrate—Pruritus—Calcipotriol—psoriasis	0.000812	0.00869	CcSEcCtD
Gallium nitrate—Erythema—Fluocinonide—psoriasis	0.000793	0.00849	CcSEcCtD
Gallium nitrate—Pleural effusion—Mycophenolate mofetil—psoriasis	0.000769	0.00824	CcSEcCtD
Gallium nitrate—Optic neuritis—Dexamethasone—psoriasis	0.000745	0.00798	CcSEcCtD
Gallium nitrate—Optic neuritis—Betamethasone—psoriasis	0.000745	0.00798	CcSEcCtD
Gallium nitrate—Rash—Calcipotriol—psoriasis	0.000724	0.00775	CcSEcCtD
Gallium nitrate—Dermatitis—Calcipotriol—psoriasis	0.000723	0.00774	CcSEcCtD
Gallium nitrate—Lung infiltration—Methotrexate—psoriasis	0.000712	0.00762	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Cyclosporine—psoriasis	0.000707	0.00757	CcSEcCtD
Gallium nitrate—Renal failure acute—Hydroxyurea—psoriasis	0.000701	0.0075	CcSEcCtD
Gallium nitrate—Optic neuritis—Prednisone—psoriasis	0.000649	0.00695	CcSEcCtD
Gallium nitrate—Paraesthesia—Clobetasol propionate—psoriasis	0.000644	0.0069	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Mycophenolate mofetil—psoriasis	0.000643	0.00689	CcSEcCtD
Gallium nitrate—Hearing impaired—Cyclosporine—psoriasis	0.000634	0.00679	CcSEcCtD
Gallium nitrate—IL1B—NOD pathway—NFKBIA—psoriasis	0.000626	0.00445	CbGpPWpGaD
Gallium nitrate—Erythema—Methoxsalen—psoriasis	0.000626	0.0067	CcSEcCtD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—NFKB1—psoriasis	0.000613	0.00436	CbGpPWpGaD
Gallium nitrate—Pruritus—Tazarotene—psoriasis	0.000599	0.00641	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—CD8A—psoriasis	0.000595	0.00423	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000592	0.00421	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—CAT—psoriasis	0.000591	0.0042	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Mycophenolic acid—psoriasis	0.000587	0.00628	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—IL4—psoriasis	0.000586	0.00416	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	0.00058	0.00412	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL13—psoriasis	0.000578	0.00411	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—CRP—psoriasis	0.000576	0.0041	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000567	0.00403	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—APOE—psoriasis	0.000564	0.00401	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Acitretin—psoriasis	0.000562	0.00601	CcSEcCtD
Gallium nitrate—Erythema—Calcitriol—psoriasis	0.000558	0.00597	CcSEcCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—TYK2—psoriasis	0.000556	0.00396	CbGpPWpGaD
Gallium nitrate—Coma—Cyclosporine—psoriasis	0.000552	0.00591	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.000551	0.00392	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—STAT3—psoriasis	0.000543	0.00386	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—IL4—psoriasis	0.000543	0.00386	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IL12B—psoriasis	0.000538	0.00383	CbGpPWpGaD
Gallium nitrate—Rash—Tazarotene—psoriasis	0.000534	0.00571	CcSEcCtD
Gallium nitrate—Dermatitis—Tazarotene—psoriasis	0.000533	0.00571	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—JUN—psoriasis	0.000533	0.00379	CbGpPWpGaD
Gallium nitrate—Tinnitus—Acitretin—psoriasis	0.000531	0.00569	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—HLA-A—psoriasis	0.00053	0.00377	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—ICAM1—psoriasis	0.00053	0.00377	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Clobetasol propionate—psoriasis	0.000529	0.00566	CcSEcCtD
Gallium nitrate—RRM2—Nucleotide metabolism—CAT—psoriasis	0.000526	0.00374	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—TYK2—psoriasis	0.000525	0.00373	CbGpPWpGaD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—IFNG—psoriasis	0.000521	0.0037	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IFNG—psoriasis	0.000521	0.0037	CbGpPWpGaD
Gallium nitrate—Encephalopathy—Methotrexate—psoriasis	0.00052	0.00557	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—STAT3—psoriasis	0.000517	0.00367	CbGpPWpGaD
Gallium nitrate—BGLAP—Notch-mediated HES/HEY network—STAT3—psoriasis	0.000515	0.00366	CbGpPWpGaD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—TNF—psoriasis	0.000511	0.00363	CbGpPWpGaD
Gallium nitrate—Pruritus—Clobetasol propionate—psoriasis	0.000508	0.00543	CcSEcCtD
Gallium nitrate—IL1B—Methylprednisolone—Clobetasol propionate—psoriasis	0.000506	0.0766	CbGdCrCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—CD4—psoriasis	0.000503	0.00358	CbGpPWpGaD
Gallium nitrate—Erythema—Acitretin—psoriasis	0.000496	0.00531	CcSEcCtD
Gallium nitrate—Erythema—Fluocinolone Acetonide—psoriasis	0.000495	0.0053	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—NFKBIA—psoriasis	0.000495	0.00352	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNFAIP3—psoriasis	0.000488	0.00347	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—HLA-DRB1—psoriasis	0.000485	0.00345	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL10—psoriasis	0.000483	0.00343	CbGpPWpGaD
Gallium nitrate—IL1B—IL1-mediated signaling events—JUN—psoriasis	0.000482	0.00343	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Fluocinonide—psoriasis	0.000477	0.0051	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—IL4—psoriasis	0.00047	0.00334	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—CAT—psoriasis	0.000469	0.00334	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—CRP—psoriasis	0.000469	0.00333	CbGpPWpGaD
Gallium nitrate—IL1B—IL1-mediated signaling events—NFKB1—psoriasis	0.000464	0.0033	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Mycophenolate mofetil—psoriasis	0.000463	0.00496	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—IFNG—psoriasis	0.000462	0.00329	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—NOS2—psoriasis	0.000461	0.00328	CbGpPWpGaD
Gallium nitrate—BGLAP—FGF signaling pathway—STAT3—psoriasis	0.000461	0.00328	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-B—psoriasis	0.000459	0.00327	CbGpPWpGaD
Gallium nitrate—Pruritus—Fluocinonide—psoriasis	0.000458	0.0049	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—JUN—psoriasis	0.000454	0.00323	CbGpPWpGaD
Gallium nitrate—Rash—Clobetasol propionate—psoriasis	0.000452	0.00484	CcSEcCtD
Gallium nitrate—Dermatitis—Clobetasol propionate—psoriasis	0.000452	0.00484	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL13—psoriasis	0.000448	0.00319	CbGpPWpGaD
Gallium nitrate—Lethargy—Cyclosporine—psoriasis	0.000447	0.00479	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—TNF—psoriasis	0.000447	0.00318	CbGpPWpGaD
Gallium nitrate—Hallucination—Hydroxyurea—psoriasis	0.000445	0.00477	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000441	0.00314	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000438	0.00311	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Methotrexate—psoriasis	0.000436	0.00467	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.000435	0.0031	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TNF—psoriasis	0.000434	0.00309	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—NFKB1—psoriasis	0.000434	0.00308	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—DDX58—psoriasis	0.000433	0.00308	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—ICAM1—psoriasis	0.000431	0.00306	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—CD8A—psoriasis	0.00043	0.00306	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-A—psoriasis	0.000426	0.00303	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Methoxsalen—psoriasis	0.000421	0.00451	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IL12B—psoriasis	0.00042	0.00299	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000415	0.00295	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—LEP—psoriasis	0.000414	0.00295	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—VEGFA—psoriasis	0.000412	0.00293	CbGpPWpGaD
Gallium nitrate—Rash—Beclomethasone—psoriasis	0.000412	0.00441	CcSEcCtD
Gallium nitrate—Dermatitis—Beclomethasone—psoriasis	0.000411	0.0044	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.00041	0.00292	CbGpPWpGaD
Gallium nitrate—Rash—Fluocinonide—psoriasis	0.000408	0.00437	CcSEcCtD
Gallium nitrate—Dermatitis—Fluocinonide—psoriasis	0.000408	0.00436	CcSEcCtD
Gallium nitrate—IL1B—Interleukin-1 signaling—NFKB1—psoriasis	0.000407	0.0029	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Fluocinonide—psoriasis	0.000405	0.0613	CbGdCrCtD
Gallium nitrate—Body temperature increased—Methoxsalen—psoriasis	0.000404	0.00432	CcSEcCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—IFNG—psoriasis	0.000403	0.00287	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—CP—psoriasis	0.000402	0.00286	CbGpPWpGaD
Gallium nitrate—Lethargy—Hydrocortisone—psoriasis	0.000398	0.00426	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—APOE—psoriasis	0.000397	0.00283	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000394	0.0596	CbGdCrCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—STAT3—psoriasis	0.00039	0.00277	CbGpPWpGaD
Gallium nitrate—Erythema—Hydroxyurea—psoriasis	0.00039	0.00417	CcSEcCtD
Gallium nitrate—Constipation—Calcitriol—psoriasis	0.000389	0.00417	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—HLA-DRB1—psoriasis	0.000389	0.00277	CbGpPWpGaD
Gallium nitrate—Nausea—Beclomethasone—psoriasis	0.000388	0.00415	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000384	0.00273	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000381	0.00271	CbGpPWpGaD
Gallium nitrate—IL1B—Monoamine Transport—TNF—psoriasis	0.000379	0.00269	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000378	0.00269	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—TYK2—psoriasis	0.000378	0.00269	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Methoxsalen—psoriasis	0.000376	0.00403	CcSEcCtD
Gallium nitrate—Hallucination—Mycophenolic acid—psoriasis	0.000373	0.00399	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—CRP—psoriasis	0.000373	0.00265	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Mycophenolic acid—psoriasis	0.000369	0.00395	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000367	0.00261	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—JUN—psoriasis	0.000366	0.0026	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Acitretin—psoriasis	0.000364	0.00389	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL10—psoriasis	0.000361	0.00257	CbGpPWpGaD
Gallium nitrate—Pruritus—Methoxsalen—psoriasis	0.000361	0.00387	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—IL6—psoriasis	0.000361	0.00257	CbGpPWpGaD
Gallium nitrate—Anaemia—Hydroxyurea—psoriasis	0.00036	0.00386	CcSEcCtD
Gallium nitrate—Body temperature increased—Calcitriol—psoriasis	0.00036	0.00385	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—IFNG—psoriasis	0.000354	0.00252	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—PCNA—psoriasis	0.000351	0.0025	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL6—psoriasis	0.00035	0.00249	CbGpPWpGaD
Gallium nitrate—Tinnitus—Mycophenolic acid—psoriasis	0.000349	0.00374	CcSEcCtD
Gallium nitrate—Leukopenia—Hydroxyurea—psoriasis	0.000349	0.00373	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—PCNA—psoriasis	0.000347	0.00247	CbGpPWpGaD
Gallium nitrate—Constipation—Acitretin—psoriasis	0.000346	0.00371	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—STAT3—psoriasis	0.000346	0.00246	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	0.000343	0.00244	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—ICAM1—psoriasis	0.000342	0.00243	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—CD4—psoriasis	0.000342	0.00243	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL4—psoriasis	0.000341	0.00242	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HCAR2—psoriasis	0.00034	0.00242	CbGpPWpGaD
Gallium nitrate—Lethargy—Dexamethasone—psoriasis	0.00034	0.00364	CcSEcCtD
Gallium nitrate—Lethargy—Betamethasone—psoriasis	0.00034	0.00364	CcSEcCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—psoriasis	0.000337	0.0024	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000335	0.00238	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Calcitriol—psoriasis	0.000335	0.00359	CcSEcCtD
Gallium nitrate—Feeling abnormal—Acitretin—psoriasis	0.000334	0.00357	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—NFKBIA—psoriasis	0.000334	0.00237	CbGpPWpGaD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—TP53—psoriasis	0.000332	0.00236	CbGpPWpGaD
Gallium nitrate—IL1B—IL-1 signaling pathway—JUN—psoriasis	0.000328	0.00233	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—IFNG—psoriasis	0.000328	0.00233	CbGpPWpGaD
Gallium nitrate—Pruritus—Calcitriol—psoriasis	0.000322	0.00345	CcSEcCtD
Gallium nitrate—Rash—Methoxsalen—psoriasis	0.000322	0.00345	CcSEcCtD
Gallium nitrate—Dermatitis—Methoxsalen—psoriasis	0.000322	0.00344	CcSEcCtD
Gallium nitrate—Body temperature increased—Acitretin—psoriasis	0.00032	0.00343	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.000319	0.00227	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000319	0.00342	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—NFKB1—psoriasis	0.000316	0.00225	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KIR2DS1—psoriasis	0.000314	0.00223	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Clobetasol propionate—psoriasis	0.000313	0.0475	CbGdCrCtD
Gallium nitrate—Diarrhoea—Calcitriol—psoriasis	0.000311	0.00333	CcSEcCtD
Gallium nitrate—Coma—Methotrexate—psoriasis	0.000305	0.00326	CcSEcCtD
Gallium nitrate—Nausea—Methoxsalen—psoriasis	0.000303	0.00325	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	0.000302	0.00215	CbGpPWpGaD
Gallium nitrate—Anaemia—Mycophenolic acid—psoriasis	0.000302	0.00323	CcSEcCtD
Gallium nitrate—Hypersensitivity—Acitretin—psoriasis	0.000298	0.00319	CcSEcCtD
Gallium nitrate—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000298	0.00319	CcSEcCtD
Gallium nitrate—Lethargy—Prednisone—psoriasis	0.000296	0.00317	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TAGAP—psoriasis	0.000295	0.0021	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—NFKB1—psoriasis	0.000295	0.00209	CbGpPWpGaD
Gallium nitrate—Hallucination—Mycophenolate mofetil—psoriasis	0.000294	0.00315	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000292	0.00208	CbGpPWpGaD
Gallium nitrate—Leukopenia—Mycophenolic acid—psoriasis	0.000292	0.00313	CcSEcCtD
Gallium nitrate—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000291	0.00312	CcSEcCtD
Gallium nitrate—Vomiting—Calcitriol—psoriasis	0.000289	0.0031	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—LEP—psoriasis	0.000288	0.00205	CbGpPWpGaD
Gallium nitrate—Rash—Calcitriol—psoriasis	0.000287	0.00307	CcSEcCtD
Gallium nitrate—Dermatitis—Calcitriol—psoriasis	0.000287	0.00307	CcSEcCtD
Gallium nitrate—Pruritus—Acitretin—psoriasis	0.000287	0.00307	CcSEcCtD
Gallium nitrate—Pruritus—Fluocinolone Acetonide—psoriasis	0.000286	0.00306	CcSEcCtD
Gallium nitrate—TF—Differentiation Pathway—IL6—psoriasis	0.000285	0.00203	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IFNG—psoriasis	0.000284	0.00202	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Hydroxyurea—psoriasis	0.000283	0.00303	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000283	0.00201	CbGpPWpGaD
Gallium nitrate—Tinnitus—Cyclosporine—psoriasis	0.000283	0.00303	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-C—psoriasis	0.000282	0.00201	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL10—psoriasis	0.00028	0.00199	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Acitretin—psoriasis	0.000277	0.00297	CcSEcCtD
Gallium nitrate—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000276	0.00296	CcSEcCtD
Gallium nitrate—Tinnitus—Mycophenolate mofetil—psoriasis	0.000276	0.00295	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—VEGFA—psoriasis	0.000274	0.00195	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—NFKB1—psoriasis	0.000273	0.00194	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IL6—psoriasis	0.000272	0.00194	CbGpPWpGaD
Gallium nitrate—Constipation—Hydroxyurea—psoriasis	0.000272	0.00291	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—ICAM1—psoriasis	0.000271	0.00193	CbGpPWpGaD
Gallium nitrate—Nausea—Calcitriol—psoriasis	0.00027	0.00289	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—NOS2—psoriasis	0.000269	0.00191	CbGpPWpGaD
Gallium nitrate—Confusional state—Mycophenolic acid—psoriasis	0.000268	0.00287	CcSEcCtD
Gallium nitrate—Hallucination—Hydrocortisone—psoriasis	0.000268	0.00287	CcSEcCtD
Gallium nitrate—IL1B—IL12-mediated signaling events—STAT3—psoriasis	0.000265	0.00188	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CXCL8—psoriasis	0.000264	0.00188	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—ITGAL—psoriasis	0.000263	0.00187	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000263	0.00187	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Methotrexate—psoriasis	0.000262	0.00281	CcSEcCtD
Gallium nitrate—Feeling abnormal—Hydroxyurea—psoriasis	0.000262	0.00281	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.000261	0.00186	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—psoriasis	0.000261	0.00186	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—IFNG—psoriasis	0.000261	0.00185	CbGpPWpGaD
Gallium nitrate—Tachycardia—Mycophenolic acid—psoriasis	0.00026	0.00278	CcSEcCtD
Gallium nitrate—Vomiting—Acitretin—psoriasis	0.000257	0.00276	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—IL6—psoriasis	0.000257	0.00183	CbGpPWpGaD
Gallium nitrate—Vomiting—Fluocinolone Acetonide—psoriasis	0.000257	0.00275	CcSEcCtD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.000256	0.00182	CbGpPWpGaD
Gallium nitrate—Rash—Acitretin—psoriasis	0.000255	0.00273	CcSEcCtD
Gallium nitrate—Dermatitis—Acitretin—psoriasis	0.000255	0.00273	CcSEcCtD
Gallium nitrate—Rash—Fluocinolone Acetonide—psoriasis	0.000255	0.00273	CcSEcCtD
Gallium nitrate—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000254	0.00272	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000252	0.00179	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Hydroxyurea—psoriasis	0.000251	0.00269	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Beclomethasone—psoriasis	0.000251	0.038	CbGdCrCtD
Gallium nitrate—IL1B—Fluorometholone—Fluocinonide—psoriasis	0.000251	0.038	CbGdCrCtD
Gallium nitrate—Lethargy—Methotrexate—psoriasis	0.000247	0.00265	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—CD4—psoriasis	0.000247	0.00176	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—NFKB1—psoriasis	0.000246	0.00175	CbGpPWpGaD
Gallium nitrate—Anaemia—Cyclosporine—psoriasis	0.000244	0.00261	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.000244	0.0369	CbGdCrCtD
Gallium nitrate—Nausea—Acitretin—psoriasis	0.000241	0.00258	CcSEcCtD
Gallium nitrate—Erythema—Prednisolone—psoriasis	0.00024	0.00257	CcSEcCtD
Gallium nitrate—Nausea—Fluocinolone Acetonide—psoriasis	0.00024	0.00257	CcSEcCtD
Gallium nitrate—Paraesthesia—Mycophenolic acid—psoriasis	0.000239	0.00256	CcSEcCtD
Gallium nitrate—Anaemia—Mycophenolate mofetil—psoriasis	0.000238	0.00255	CcSEcCtD
Gallium nitrate—Dyspnoea—Mycophenolic acid—psoriasis	0.000237	0.00254	CcSEcCtD
Gallium nitrate—Leukopenia—Cyclosporine—psoriasis	0.000236	0.00253	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—TYK2—psoriasis	0.000236	0.00168	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	0.000236	0.00168	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—PTTG1—psoriasis	0.000235	0.00167	CbGpPWpGaD
Gallium nitrate—Erythema—Hydrocortisone—psoriasis	0.000235	0.00251	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-E—psoriasis	0.000234	0.00167	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Hydroxyurea—psoriasis	0.000234	0.00251	CcSEcCtD
Gallium nitrate—Leukopenia—Mycophenolate mofetil—psoriasis	0.00023	0.00247	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.00023	0.00164	CbGpPWpGaD
Gallium nitrate—Hallucination—Dexamethasone—psoriasis	0.000229	0.00245	CcSEcCtD
Gallium nitrate—Hallucination—Betamethasone—psoriasis	0.000229	0.00245	CcSEcCtD
Gallium nitrate—Constipation—Mycophenolic acid—psoriasis	0.000228	0.00244	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IFNG—psoriasis	0.000226	0.00161	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—STAT3—psoriasis	0.000221	0.00157	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—JUN—psoriasis	0.000221	0.00157	CbGpPWpGaD
Gallium nitrate—Erythema—Triamcinolone—psoriasis	0.000221	0.00236	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—CP—psoriasis	0.00022	0.00157	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Mycophenolic acid—psoriasis	0.000219	0.00235	CcSEcCtD
Gallium nitrate—Diarrhoea—Hydroxyurea—psoriasis	0.000218	0.00233	CcSEcCtD
Gallium nitrate—Confusional state—Cyclosporine—psoriasis	0.000217	0.00233	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—NFKB1—psoriasis	0.000217	0.00154	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	0.000215	0.00153	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—VEGFA—psoriasis	0.000214	0.00153	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—NFKB1—psoriasis	0.000213	0.00151	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—TNF—psoriasis	0.000212	0.00151	CbGpPWpGaD
Gallium nitrate—Confusional state—Mycophenolate mofetil—psoriasis	0.000212	0.00227	CcSEcCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—IL6—psoriasis	0.000211	0.0015	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Mycophenolic acid—psoriasis	0.000211	0.00225	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CXCL8—psoriasis	0.00021	0.0015	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—CARM1—psoriasis	0.00021	0.00149	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Clobetasol propionate—psoriasis	0.000209	0.0317	CbGdCrCtD
Gallium nitrate—IL1B—Spinal Cord Injury—IFNG—psoriasis	0.000206	0.00146	CbGpPWpGaD
Gallium nitrate—Tachycardia—Mycophenolate mofetil—psoriasis	0.000205	0.0022	CcSEcCtD
Gallium nitrate—Vomiting—Hydroxyurea—psoriasis	0.000202	0.00216	CcSEcCtD
Gallium nitrate—Rash—Hydroxyurea—psoriasis	0.0002	0.00215	CcSEcCtD
Gallium nitrate—Erythema—Dexamethasone—psoriasis	0.0002	0.00215	CcSEcCtD
Gallium nitrate—Erythema—Betamethasone—psoriasis	0.0002	0.00215	CcSEcCtD
Gallium nitrate—Dermatitis—Hydroxyurea—psoriasis	0.0002	0.00214	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—JUN—psoriasis	0.0002	0.00142	CbGpPWpGaD
Gallium nitrate—Hallucination—Prednisone—psoriasis	0.000199	0.00214	CcSEcCtD
Gallium nitrate—IL1B—Methylprednisolone—Hydrocortisone—psoriasis	0.000199	0.0301	CbGdCrCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000198	0.00141	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—SOCS1—psoriasis	0.000196	0.00139	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—JUN—psoriasis	0.000196	0.00139	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Cyclosporine—psoriasis	0.000193	0.00207	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	0.000193	0.00137	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Cyclosporine—psoriasis	0.000192	0.00206	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—CXCL8—psoriasis	0.000192	0.00136	CbGpPWpGaD
Gallium nitrate—Tachycardia—Prednisolone—psoriasis	0.000191	0.00205	CcSEcCtD
Gallium nitrate—Nausea—Hydroxyurea—psoriasis	0.000189	0.00202	CcSEcCtD
Gallium nitrate—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000189	0.00202	CcSEcCtD
Gallium nitrate—Pruritus—Mycophenolic acid—psoriasis	0.000188	0.00202	CcSEcCtD
Gallium nitrate—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000187	0.00201	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TP53—psoriasis	0.000187	0.00133	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NDUFA5—psoriasis	0.000187	0.00133	CbGpPWpGaD
Gallium nitrate—Tachycardia—Hydrocortisone—psoriasis	0.000187	0.002	CcSEcCtD
Gallium nitrate—IL1B—Methylprednisolone—Dexamethasone—psoriasis	0.000185	0.028	CbGdCrCtD
Gallium nitrate—IL1B—Methylprednisolone—Betamethasone—psoriasis	0.000185	0.028	CbGdCrCtD
Gallium nitrate—Constipation—Cyclosporine—psoriasis	0.000184	0.00197	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—NFKB1—psoriasis	0.000184	0.00131	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TNF—psoriasis	0.000184	0.00131	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—psoriasis	0.000184	0.00131	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—JUN—psoriasis	0.000184	0.00131	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Mycophenolic acid—psoriasis	0.000182	0.00195	CcSEcCtD
Gallium nitrate—IL1B—Methylprednisolone—Triamcinolone—psoriasis	0.00018	0.0273	CbGdCrCtD
Gallium nitrate—Constipation—Mycophenolate mofetil—psoriasis	0.00018	0.00192	CcSEcCtD
Gallium nitrate—Feeling abnormal—Cyclosporine—psoriasis	0.000178	0.0019	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000177	0.00126	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CCL20—psoriasis	0.000177	0.00126	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Prednisolone—psoriasis	0.000176	0.00188	CcSEcCtD
Gallium nitrate—Tachycardia—Triamcinolone—psoriasis	0.000176	0.00188	CcSEcCtD
Gallium nitrate—Erythema—Prednisone—psoriasis	0.000175	0.00187	CcSEcCtD
Gallium nitrate—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000173	0.00185	CcSEcCtD
Gallium nitrate—Paraesthesia—Hydrocortisone—psoriasis	0.000172	0.00184	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—IL6—psoriasis	0.000171	0.00122	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Prednisone—psoriasis	0.000171	0.0259	CbGdCrCtD
Gallium nitrate—Body temperature increased—Cyclosporine—psoriasis	0.00017	0.00182	CcSEcCtD
Gallium nitrate—Vomiting—Mycophenolic acid—psoriasis	0.000169	0.00181	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—psoriasis	0.000169	0.0012	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	0.000168	0.00119	CbGpPWpGaD
Gallium nitrate—Rash—Mycophenolic acid—psoriasis	0.000168	0.0018	CcSEcCtD
Gallium nitrate—Dermatitis—Mycophenolic acid—psoriasis	0.000168	0.0018	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Fluocinonide—psoriasis	0.000168	0.0254	CbGdCrCtD
Gallium nitrate—IL1B—Budesonide—Beclomethasone—psoriasis	0.000168	0.0254	CbGdCrCtD
Gallium nitrate—IL1B—Methylprednisolone—Prednisolone—psoriasis	0.000167	0.0253	CbGdCrCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-B—psoriasis	0.000167	0.00119	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000166	0.00178	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—STAT3—psoriasis	0.000165	0.00118	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Fluocinolone Acetonide—psoriasis	0.000163	0.0247	CbGdCrCtD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—psoriasis	0.000162	0.00115	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Triamcinolone—psoriasis	0.000162	0.00173	CcSEcCtD
Gallium nitrate—Feeling abnormal—Prednisolone—psoriasis	0.000162	0.00173	CcSEcCtD
Gallium nitrate—Anaemia—Prednisone—psoriasis	0.000161	0.00173	CcSEcCtD
Gallium nitrate—Dyspnoea—Triamcinolone—psoriasis	0.000161	0.00172	CcSEcCtD
Gallium nitrate—IL1B—Immune System—ERAP1—psoriasis	0.000161	0.00114	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000161	0.00114	CbGpPWpGaD
Gallium nitrate—Tachycardia—Betamethasone—psoriasis	0.00016	0.00171	CcSEcCtD
Gallium nitrate—Tachycardia—Dexamethasone—psoriasis	0.00016	0.00171	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—CYP2S1—psoriasis	0.000159	0.00113	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Cyclosporine—psoriasis	0.000159	0.0017	CcSEcCtD
Gallium nitrate—Nausea—Mycophenolic acid—psoriasis	0.000158	0.00169	CcSEcCtD
Gallium nitrate—Feeling abnormal—Hydrocortisone—psoriasis	0.000158	0.00169	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	0.000156	0.00111	CbGpPWpGaD
Gallium nitrate—Tinnitus—Methotrexate—psoriasis	0.000156	0.00167	CcSEcCtD
Gallium nitrate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000155	0.00166	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-A—psoriasis	0.000155	0.0011	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000153	0.00109	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000153	0.00109	CbGpPWpGaD
Gallium nitrate—Pruritus—Cyclosporine—psoriasis	0.000152	0.00163	CcSEcCtD
Gallium nitrate—Body temperature increased—Hydrocortisone—psoriasis	0.000151	0.00162	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	0.00015	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—psoriasis	0.00015	0.00107	CbGpPWpGaD
Gallium nitrate—Pruritus—Mycophenolate mofetil—psoriasis	0.000149	0.00159	CcSEcCtD
Gallium nitrate—Feeling abnormal—Triamcinolone—psoriasis	0.000149	0.00159	CcSEcCtD
Gallium nitrate—Diarrhoea—Cyclosporine—psoriasis	0.000147	0.00158	CcSEcCtD
Gallium nitrate—Paraesthesia—Betamethasone—psoriasis	0.000147	0.00157	CcSEcCtD
Gallium nitrate—Paraesthesia—Dexamethasone—psoriasis	0.000147	0.00157	CcSEcCtD
Gallium nitrate—Erythema—Methotrexate—psoriasis	0.000146	0.00156	CcSEcCtD
Gallium nitrate—Hypersensitivity—Prednisolone—psoriasis	0.000144	0.00155	CcSEcCtD
Gallium nitrate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000144	0.00154	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	0.000143	0.00102	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Triamcinolone—psoriasis	0.000143	0.00153	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—JUN—psoriasis	0.000142	0.00101	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—DDX58—psoriasis	0.000141	0.00101	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	0.000141	0.001	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Hydrocortisone—psoriasis	0.000141	0.00151	CcSEcCtD
Gallium nitrate—Tachycardia—Prednisone—psoriasis	0.000139	0.00149	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	0.000138	0.00098	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—psoriasis	0.000138	0.000978	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000137	0.000975	CbGpPWpGaD
Gallium nitrate—Vomiting—Cyclosporine—psoriasis	0.000137	0.00147	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—IL6—psoriasis	0.000136	0.000968	CbGpPWpGaD
Gallium nitrate—Rash—Cyclosporine—psoriasis	0.000136	0.00145	CcSEcCtD
Gallium nitrate—Dermatitis—Cyclosporine—psoriasis	0.000136	0.00145	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—ICAM1—psoriasis	0.000136	0.000964	CbGpPWpGaD
Gallium nitrate—Pruritus—Hydrocortisone—psoriasis	0.000135	0.00145	CcSEcCtD
Gallium nitrate—Anaemia—Methotrexate—psoriasis	0.000135	0.00144	CcSEcCtD
Gallium nitrate—Feeling abnormal—Betamethasone—psoriasis	0.000135	0.00144	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dexamethasone—psoriasis	0.000135	0.00144	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—JUN—psoriasis	0.000134	0.000955	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL6—psoriasis	0.000134	0.00095	CbGpPWpGaD
Gallium nitrate—Vomiting—Mycophenolate mofetil—psoriasis	0.000134	0.00143	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—psoriasis	0.000133	0.000948	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Triamcinolone—psoriasis	0.000133	0.00142	CcSEcCtD
Gallium nitrate—Rash—Mycophenolate mofetil—psoriasis	0.000133	0.00142	CcSEcCtD
Gallium nitrate—Dermatitis—Mycophenolate mofetil—psoriasis	0.000132	0.00142	CcSEcCtD
Gallium nitrate—Diarrhoea—Hydrocortisone—psoriasis	0.000131	0.0014	CcSEcCtD
Gallium nitrate—Leukopenia—Methotrexate—psoriasis	0.000131	0.0014	CcSEcCtD
Gallium nitrate—Body temperature increased—Betamethasone—psoriasis	0.000129	0.00138	CcSEcCtD
Gallium nitrate—Body temperature increased—Dexamethasone—psoriasis	0.000129	0.00138	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NFKB1—psoriasis	0.000129	0.000919	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—psoriasis	0.000129	0.000918	CbGpPWpGaD
Gallium nitrate—IL1B—Betamethasone—Clobetasol propionate—psoriasis	0.000128	0.0194	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Clobetasol propionate—psoriasis	0.000128	0.0194	CbGdCrCtD
Gallium nitrate—Nausea—Cyclosporine—psoriasis	0.000128	0.00137	CcSEcCtD
Gallium nitrate—Paraesthesia—Prednisone—psoriasis	0.000128	0.00137	CcSEcCtD
Gallium nitrate—Pruritus—Triamcinolone—psoriasis	0.000128	0.00137	CcSEcCtD
Gallium nitrate—Nausea—Mycophenolate mofetil—psoriasis	0.000125	0.00134	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000124	0.000885	CbGpPWpGaD
Gallium nitrate—Rash—Prednisolone—psoriasis	0.000124	0.00132	CcSEcCtD
Gallium nitrate—Dermatitis—Prednisolone—psoriasis	0.000123	0.00132	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Hydrocortisone—psoriasis	0.000123	0.0187	CbGdCrCtD
Gallium nitrate—Constipation—Prednisone—psoriasis	0.000122	0.0013	CcSEcCtD
Gallium nitrate—Vomiting—Hydrocortisone—psoriasis	0.000122	0.0013	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000121	0.000864	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000121	0.00086	CbGpPWpGaD
Gallium nitrate—Rash—Hydrocortisone—psoriasis	0.000121	0.00129	CcSEcCtD
Gallium nitrate—Dermatitis—Hydrocortisone—psoriasis	0.000121	0.00129	CcSEcCtD
Gallium nitrate—Confusional state—Methotrexate—psoriasis	0.00012	0.00129	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL6—psoriasis	0.000118	0.00084	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—psoriasis	0.000118	0.000836	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Prednisone—psoriasis	0.000117	0.00126	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000117	0.000832	CbGpPWpGaD
Gallium nitrate—Nausea—Prednisolone—psoriasis	0.000116	0.00125	CcSEcCtD
Gallium nitrate—Pruritus—Dexamethasone—psoriasis	0.000116	0.00124	CcSEcCtD
Gallium nitrate—Pruritus—Betamethasone—psoriasis	0.000116	0.00124	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—IL6—psoriasis	0.000116	0.000821	CbGpPWpGaD
Gallium nitrate—Vomiting—Triamcinolone—psoriasis	0.000115	0.00123	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Dexamethasone—psoriasis	0.000114	0.0173	CbGdCrCtD
Gallium nitrate—IL1B—Fluorometholone—Betamethasone—psoriasis	0.000114	0.0173	CbGdCrCtD
Gallium nitrate—Nausea—Hydrocortisone—psoriasis	0.000114	0.00122	CcSEcCtD
Gallium nitrate—Rash—Triamcinolone—psoriasis	0.000114	0.00122	CcSEcCtD
Gallium nitrate—Dermatitis—Triamcinolone—psoriasis	0.000114	0.00122	CcSEcCtD
Gallium nitrate—Body temperature increased—Prednisone—psoriasis	0.000113	0.00121	CcSEcCtD
Gallium nitrate—Diarrhoea—Betamethasone—psoriasis	0.000112	0.0012	CcSEcCtD
Gallium nitrate—Diarrhoea—Dexamethasone—psoriasis	0.000112	0.0012	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Triamcinolone—psoriasis	0.000112	0.0169	CbGdCrCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL6—psoriasis	0.000111	0.000789	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—TYK2—psoriasis	0.00011	0.000784	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HLA-A—psoriasis	0.00011	0.000781	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—NOS2—psoriasis	0.000108	0.000769	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL6—psoriasis	0.000108	0.000765	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—PCNA—psoriasis	0.000107	0.000762	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ITGAL—psoriasis	0.000107	0.000762	CbGpPWpGaD
Gallium nitrate—Nausea—Triamcinolone—psoriasis	0.000107	0.00115	CcSEcCtD
Gallium nitrate—Paraesthesia—Methotrexate—psoriasis	0.000107	0.00114	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—psoriasis	0.000107	0.000758	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Methotrexate—psoriasis	0.000106	0.00114	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Prednisone—psoriasis	0.000106	0.0161	CbGdCrCtD
Gallium nitrate—Hypersensitivity—Prednisone—psoriasis	0.000105	0.00112	CcSEcCtD
Gallium nitrate—Vomiting—Betamethasone—psoriasis	0.000104	0.00111	CcSEcCtD
Gallium nitrate—Vomiting—Dexamethasone—psoriasis	0.000104	0.00111	CcSEcCtD
Gallium nitrate—IL1B—Fluorometholone—Prednisolone—psoriasis	0.000104	0.0157	CbGdCrCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IFNG—psoriasis	0.000103	0.000734	CbGpPWpGaD
Gallium nitrate—Rash—Dexamethasone—psoriasis	0.000103	0.0011	CcSEcCtD
Gallium nitrate—Rash—Betamethasone—psoriasis	0.000103	0.0011	CcSEcCtD
Gallium nitrate—Dermatitis—Dexamethasone—psoriasis	0.000103	0.0011	CcSEcCtD
Gallium nitrate—Dermatitis—Betamethasone—psoriasis	0.000103	0.0011	CcSEcCtD
Gallium nitrate—IL1B—Dexamethasone—Beclomethasone—psoriasis	0.000103	0.0155	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Fluocinonide—psoriasis	0.000103	0.0155	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Beclomethasone—psoriasis	0.000103	0.0155	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Fluocinonide—psoriasis	0.000103	0.0155	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Disease—APOE—psoriasis	0.000103	0.000729	CbGpPWpGaD
Gallium nitrate—Pruritus—Prednisone—psoriasis	0.000101	0.00108	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—psoriasis	0.000101	0.000715	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—REL—psoriasis	0.0001	0.000712	CbGpPWpGaD
Gallium nitrate—IL1B—Dexamethasone—Fluocinolone Acetonide—psoriasis	9.96e-05	0.0151	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Fluocinolone Acetonide—psoriasis	9.96e-05	0.0151	CbGdCrCtD
Gallium nitrate—Feeling abnormal—Methotrexate—psoriasis	9.81e-05	0.00105	CcSEcCtD
Gallium nitrate—Diarrhoea—Prednisone—psoriasis	9.75e-05	0.00104	CcSEcCtD
Gallium nitrate—IL1B—Immune System—IFIH1—psoriasis	9.73e-05	0.000692	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SOCS1—psoriasis	9.73e-05	0.000692	CbGpPWpGaD
Gallium nitrate—Nausea—Dexamethasone—psoriasis	9.72e-05	0.00104	CcSEcCtD
Gallium nitrate—Nausea—Betamethasone—psoriasis	9.72e-05	0.00104	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—PCNA—psoriasis	9.59e-05	0.000682	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—NOS2—psoriasis	9.55e-05	0.000679	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	9.44e-05	0.000671	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Methotrexate—psoriasis	9.41e-05	0.00101	CcSEcCtD
Gallium nitrate—IL1B—Immune System—HLA-C—psoriasis	9.22e-05	0.000656	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TNFAIP3—psoriasis	9.11e-05	0.000648	CbGpPWpGaD
Gallium nitrate—Vomiting—Prednisone—psoriasis	9.06e-05	0.00097	CcSEcCtD
Gallium nitrate—Rash—Prednisone—psoriasis	8.98e-05	0.000962	CcSEcCtD
Gallium nitrate—Dermatitis—Prednisone—psoriasis	8.97e-05	0.000961	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—psoriasis	8.86e-05	0.00063	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Methotrexate—psoriasis	8.77e-05	0.000939	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	8.65e-05	0.000615	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL6—psoriasis	8.61e-05	0.000612	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—NFKB1—psoriasis	8.59e-05	0.000611	CbGpPWpGaD
Gallium nitrate—Nausea—Prednisone—psoriasis	8.46e-05	0.000906	CcSEcCtD
Gallium nitrate—Pruritus—Methotrexate—psoriasis	8.42e-05	0.000902	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Hydrocortisone—psoriasis	8.22e-05	0.0125	CbGdCrCtD
Gallium nitrate—Diarrhoea—Methotrexate—psoriasis	8.15e-05	0.000872	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—TYK2—psoriasis	7.82e-05	0.000556	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CARM1—psoriasis	7.77e-05	0.000552	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—STAT3—psoriasis	7.72e-05	0.000549	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-E—psoriasis	7.65e-05	0.000544	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Dexamethasone—psoriasis	7.64e-05	0.0116	CbGdCrCtD
Gallium nitrate—IL1B—Budesonide—Betamethasone—psoriasis	7.64e-05	0.0116	CbGdCrCtD
Gallium nitrate—Vomiting—Methotrexate—psoriasis	7.57e-05	0.00081	CcSEcCtD
Gallium nitrate—Rash—Methotrexate—psoriasis	7.51e-05	0.000804	CcSEcCtD
Gallium nitrate—Dermatitis—Methotrexate—psoriasis	7.5e-05	0.000803	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Triamcinolone—psoriasis	7.46e-05	0.0113	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—APOE—psoriasis	7.18e-05	0.00051	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—LEP—psoriasis	7.18e-05	0.00051	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Prednisone—psoriasis	7.08e-05	0.0107	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Disease—CD4—psoriasis	7.08e-05	0.000503	CbGpPWpGaD
Gallium nitrate—Nausea—Methotrexate—psoriasis	7.07e-05	0.000757	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Prednisolone—psoriasis	6.91e-05	0.0105	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NFKBIA—psoriasis	6.69e-05	0.000476	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—SOCS1—psoriasis	6.39e-05	0.000454	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—VEGFA—psoriasis	6.26e-05	0.000445	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD8A—psoriasis	5.67e-05	0.000403	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TYK2—psoriasis	5.48e-05	0.00039	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—STAT3—psoriasis	5.48e-05	0.00039	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-B—psoriasis	5.45e-05	0.000388	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL6—psoriasis	5.39e-05	0.000383	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-A—psoriasis	5.05e-05	0.000359	CbGpPWpGaD
Gallium nitrate—IL1B—Betamethasone—Hydrocortisone—psoriasis	5.03e-05	0.00762	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Hydrocortisone—psoriasis	5.03e-05	0.00762	CbGdCrCtD
Gallium nitrate—IL1B—Immune System—CRP—psoriasis	4.82e-05	0.000343	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CAT—psoriasis	4.78e-05	0.00034	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CXCL8—psoriasis	4.77e-05	0.000339	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—psoriasis	4.73e-05	0.000336	CbGpPWpGaD
Gallium nitrate—IL1B—Dexamethasone—Betamethasone—psoriasis	4.67e-05	0.00708	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Dexamethasone—psoriasis	4.67e-05	0.00708	CbGdCrCtD
Gallium nitrate—IL1B—Immune System—HLA-DRB1—psoriasis	4.62e-05	0.000328	CbGpPWpGaD
Gallium nitrate—IL1B—Dexamethasone—Triamcinolone—psoriasis	4.57e-05	0.00691	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Triamcinolone—psoriasis	4.57e-05	0.00691	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—JUN—psoriasis	4.43e-05	0.000315	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ICAM1—psoriasis	4.43e-05	0.000315	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—NFKBIA—psoriasis	4.4e-05	0.000313	CbGpPWpGaD
Gallium nitrate—IL1B—Dexamethasone—Prednisone—psoriasis	4.33e-05	0.00656	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Prednisone—psoriasis	4.33e-05	0.00656	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NFKB1—psoriasis	4.27e-05	0.000304	CbGpPWpGaD
Gallium nitrate—IL1B—Dexamethasone—Prednisolone—psoriasis	4.23e-05	0.0064	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Prednisolone—psoriasis	4.23e-05	0.0064	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—VEGFA—psoriasis	3.87e-05	0.000275	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—STAT3—psoriasis	3.84e-05	0.000273	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—IL6—psoriasis	3.83e-05	0.000272	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—APOE—psoriasis	3.71e-05	0.000264	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TYK2—psoriasis	3.6e-05	0.000256	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—psoriasis	3.53e-05	0.000251	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFNG—psoriasis	3.37e-05	0.00024	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD4—psoriasis	3.26e-05	0.000231	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PPARG—psoriasis	3.23e-05	0.00023	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—psoriasis	2.93e-05	0.000208	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—JUN—psoriasis	2.91e-05	0.000207	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—NFKB1—psoriasis	2.81e-05	0.000199	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL6—psoriasis	2.68e-05	0.000191	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—STAT3—psoriasis	2.52e-05	0.000179	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL6—psoriasis	1.76e-05	0.000125	CbGpPWpGaD
